These people may need direct supplementation with methylcobalamin or adenosylcobalamin rather than cyanocobalamin
Weight loss Available in NZ = Liraglutide high dose (Saxenda, daily injection) Self-funding needed ($500-600/month) Not available in NZ = Semaglutide (Ozempic, Wegovy) or Tirzepatide (Mounjaro), as of May 2023 Side effects, particularly upper gastrointestinal, are common with GLP-1 agonist initiation
If you think of all the possible mechanisms, across GLP-1, GIP, amylin, and even cannabinoid receptors, you get a giant Venn diagram of overlapping options
Written by Elizabeth Tito, BSc Genetics, MPH Elizabeth is a science and medical writer with a background in Genetics and Public Health
Assessment of liver marker enzymes and its association with type 2 diabetes mellitus in Northwest Ethiopia
It binds to GLP-1 receptors, enhancing insulin secretion, reducing glucagon production, and slowing digestion